Advanced Enzyme Technologies Reports 15% Revenue Growth in 9M FY26

Advanced Enzyme Technologies Limited, a leading specialty biotech company, announced its unaudited financial results for the third quarter and nine months ended December 2025. The company reported a 2% increase in revenue on a y-o-y basis, reaching INR 5,424 million in 9M FY26. The EBITDA margin stood at 31%, PBT margin at 32%, and PAT margin at 24% during the 9M FY26. The Human Nutrition segment reported 12% growth, the Animal Nutrition segment 26%, and the Bio-Processing segment 15%. The Specialized Manufacturing segment grew by 25%. The company's EPS also increased by 20% in 9M FY26.